VTRS
Viatris Inc
NASDAQ: VTRS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$14.97
+1.01% today
Updated 2026-04-29
Market cap
$17.43B
P/E ratio
—
P/S ratio
1.22x
EPS (TTM)
$-3.00
Dividend yield
3.24%
52W range
$8 – $16
Volume
10.4M
Viatris Inc (VTRS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $390.19M | $167.69M | $384.45M | $605.08M | $931.40M | $720.42M | $949.02M | $1.11B | $1.01B | $2.01B | $2.05B | $2.06B | $2.34B | $1.80B | $1.23B | $3.02B | $2.95B | $2.80B | $2.30B | $2.32B |
| Capital expenditures | $161.85M | $110.54M | $165.11M | $154.40M | $192.79M | $279.85M | $305.32M | $334.60M | $325.30M | $362.90M | $390.40M | $275.90M | $252.10M | $406.00M | $681.20M | $509.40M | $443.00M | $474.50M | $326.00M | $378.80M |
| Depreciation | $61.51M | $210.40M | $425.28M | $401.16M | $422.79M | $494.49M | $546.60M | $498.00M | $538.90M | $1.10B | $1.49B | $1.73B | $1.89B | $2.02B | $2.22B | $4.51B | $3.03B | $2.74B | $2.71B | — |
| Stock-based comp | $-578000.00 | — | $30.64M | $31.17M | $31.39M | $42.58M | $42.58M | $47.00M | $66.00M | $92.80M | $88.90M | $74.70M | $-70.60M | $56.80M | $79.20M | $111.20M | $116.40M | $180.70M | $146.10M | $177.70M |
| Free cash flow | $228.34M | $57.15M | $219.33M | $450.67M | $738.61M | $440.58M | $643.69M | $772.00M | $689.50M | $1.65B | $1.66B | $1.79B | $2.09B | $1.40B | $550.60M | $2.51B | $2.51B | $2.33B | $1.98B | $1.94B |
| Investing cash flow | — | $-7.04B | $-152.83M | $-327.54M | $-750.28M | $-347.07M | $-371.21M | $-1.87B | $-800.30M | $-1.57B | $-7.68B | $-976.40M | $-1.21B | $-525.40M | $-301.10M | $-117.80M | $1.52B | $-764.10M | $1.80B | — |
| Financing cash flow | $1.44B | $6.07B | $-166.94M | $-454.43M | $100.35M | $-645.00M | $-611.52M | $692.90M | $-267.40M | $604.80M | $5.34B | $-1.89B | $-1.09B | $-1.17B | $-605.70M | $-3.01B | $-3.88B | $-2.30B | $-4.33B | — |
| Dividends paid | $50.75M | $29.82M | $137.50M | $139.03M | $139.03M | — | — | — | — | — | — | — | $399.00M | $300000.00 | $7.90M | $399.00M | $581.60M | $575.60M | $574.80M | $561.20M |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |